James W. Newman's Insider Trades & SAST Disclosures
James W. Newman's most recent trade in Adial Pharmaceuticals Inc was a trade of 12,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James W. Newman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option | |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 26 Nov 2021 | 10,000 | 34,475 (0%) | 0% | 2.9 | 28,500 | Common Stock |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option | |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 2,544 | 152,963 (1%) | 0% | - | Common Stock | |
| Adial Pharmaceuticals Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 1,187 | 14,475 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges